“…Glioblastoma tissue (n = 4 patient samples) was cut manually into slices or fragments of various sizes up to 1 mm thick, and treated with rQNestin (0.1–5 PFU per cell, for 24 h) by adding the virus in a 100 L drop of saline to the piece of tissue submerged in 400 L of complete medium and incubated at 37 with 5% CO2 ( Smalley et al., 2020 ). Using a “sequential imaging strategy”, which we described recently ( Smalley et al., 2019 ), serial sections were then fixed and either stained with hematoxylin and eosin (H&E), or immunostained for HSV-1 (DAKO, B0114), GFP (GFP antibody CAT# AM1009a from Abgent, clone 168AT1211), or cleaved caspase-3 (Cell signaling Tech, for clone information see Goldman et al., 2015 ). The impact of rQNestin on the spatial context and activity of the immune compartment in the glioblastoma ex vivo slices was further assessed by multiplex immunohistochemistry (mIHC).…”